Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

A study in the October 2010 CGH examines safety and complications of percutaneous liver biopsy in patients with hepatitis C–related bridging fibrosis or cirrhosis who were enrolled in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Source Type: podcasts